As of 2025-06-25, the Intrinsic Value of Aarti Drugs Ltd (AARTIDRUGS.NS) is 362.81 INR. This AARTIDRUGS.NS valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 438.40 INR, the upside of Aarti Drugs Ltd is -17.20%.
The range of the Intrinsic Value is 300.44 - 454.17 INR
Based on its market price of 438.40 INR and our intrinsic valuation, Aarti Drugs Ltd (AARTIDRUGS.NS) is overvalued by 17.20%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 300.44 - 454.17 | 362.81 | -17.2% |
| DCF (Growth 10y) | 517.77 - 764.23 | 618.46 | 41.1% |
| DCF (EBITDA 5y) | 1,043.00 - 1,357.91 | 1,183.44 | 169.9% |
| DCF (EBITDA 10y) | 1,146.85 - 1,600.61 | 1,346.65 | 207.2% |
| Fair Value | 197.91 - 197.91 | 197.91 | -54.86% |
| P/E | 503.66 - 929.86 | 711.84 | 62.4% |
| EV/EBITDA | 413.48 - 916.12 | 589.11 | 34.4% |
| EPV | 99.94 - 131.27 | 115.60 | -73.6% |
| DDM - Stable | 81.91 - 152.45 | 117.18 | -73.3% |
| DDM - Multi | 286.84 - 422.98 | 342.47 | -21.9% |
| Market Cap (mil) | 40,012.77 |
| Beta | 0.97 |
| Outstanding shares (mil) | 91.27 |
| Enterprise Value (mil) | 46,087.87 |
| Market risk premium | 8.31% |
| Cost of Equity | 16.31% |
| Cost of Debt | 7.52% |
| WACC | 14.91% |